Comparison of Immediate Versus Staged Complete Revascularisation in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: A Meta-Analysis of Randomized and Non-randomized Studies
- PMID: 37746472
- PMCID: PMC10515466
- DOI: 10.7759/cureus.43968
Comparison of Immediate Versus Staged Complete Revascularisation in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: A Meta-Analysis of Randomized and Non-randomized Studies
Abstract
Acute myocardial infarction is a critical medical condition that poses a significant health burden, leading to substantial morbidity. Despite advancements in medical care, managing this condition is challenging for patients and society. The preferred approach appears to be comprehensive multivessel revascularization, yet the optimal timing remains uncertain. This study aims to compare immediate complete revascularisation and stage complete vascularization in patients presenting with acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD). The Preferred Reporting of Systematic Reviews and Meta-analysis (PRISMA) guidelines conducted the present meta-analysis. A comprehensive literature search was conducted using online databases, including PubMed, and EMBASE from 2010 onwards, to identify articles that compared cardiovascular outcomes between patients undergoing immediate and staged complete revascularization. We also searched Google Scholar for additional studies relevant to the present meta-analysis. The primary outcome assessed in this study was major adverse cardiovascular events (MACE). Secondary outcomes included all-cause mortality, cardiovascular mortality, myocardial infarction (MI), and revascularization. A total of 15 studies fulfilled pre-defined eligibility criteria and were included in the final analysis. Our analysis shows that staged revascularization is associated with improved outcomes in patients with ACS and multivessel CAD, including all-cause mortality and cardiovascular mortality, without increasing the risk of major adverse cardiovascular events, myocardial infarction, and the need for unplanned revascularization.
Keywords: acute coronary syndrome; immediate vascularization; multivessel disease; staged vascularization; systematic review and meta-analysis.
Copyright © 2023, Rawat et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures







Similar articles
-
Culprit-Only Revascularization, Single-Setting Complete Revascularization, and Staged Complete Revascularization in Acute Myocardial Infarction: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.Circ Cardiovasc Interv. 2024 Jul;17(7):e013737. doi: 10.1161/CIRCINTERVENTIONS.123.013737. Epub 2024 Jul 8. Circ Cardiovasc Interv. 2024. PMID: 38973504
-
Immediate Versus Staged Multivessel PCI Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Systematic Review and Meta-Analysis.Am J Med Sci. 2022 Feb;363(2):161-173. doi: 10.1016/j.amjms.2021.06.017. Epub 2021 Jul 15. Am J Med Sci. 2022. PMID: 34274323
-
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.Lancet. 2023 Apr 8;401(10383):1172-1182. doi: 10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. Lancet. 2023. PMID: 36889333 Clinical Trial.
-
Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials.Int J Cardiol. 2023 Dec 15;393:131397. doi: 10.1016/j.ijcard.2023.131397. Epub 2023 Sep 26. Int J Cardiol. 2023. PMID: 37769973
-
The optimal timing for intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis.Front Cardiovasc Med. 2024 Aug 9;11:1389017. doi: 10.3389/fcvm.2024.1389017. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39185134 Free PMC article.
Cited by
-
Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome.J Res Med Sci. 2024 Jul 11;29:32. doi: 10.4103/jrms.jrms_851_23. eCollection 2024. J Res Med Sci. 2024. PMID: 39239072 Free PMC article.
-
A Meta-Analysis of Timing of Complete Revascularization in Patients with ST-Elevation Myocardial Infarction.J Clin Med. 2024 Nov 24;13(23):7107. doi: 10.3390/jcm13237107. J Clin Med. 2024. PMID: 39685565 Free PMC article.
References
-
- Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Kolansky DM. https://pubmed.ncbi.nlm.nih.gov/19355807/ Am J Manag Care. 2009;15:0–41. - PubMed
-
- Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry) Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. https://pubmed.ncbi.nlm.nih.gov/20643243/ Am J Cardiol. 2010;106:342–347. - PubMed
-
- Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Sorajja P, Gersh BJ, Cox DA, et al. Eur Heart J. 2007;28:1709–1716. - PubMed
-
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI- 3—PRIMULTI): an open-label, randomised controlled trial. Engstrøm T, Kelbæk H, Helqvist S, et al. Lancet. 2015;386:665–671. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous